Professor David Y. Gin, a brilliant and talented chemist, passed away last week. He was a gentle, kind, good-humored, and remarkable human being who will be sorely missed.
David Y. Gin was working at the nexus of synthetic chemistry, clinical trials, and research to develop new, safer, and more-potent immunological and therapeutic agents for cancer and infectious diseases.
David Y. Gin was born 1967. After he received his PhD in synthetic organic chemistry from the California Institute of Technology, USA, in 1994, he went for a postdoctoral fellowship to Harvard University from 1994 – 1996. From 1996 – 2006 he was Professor of Chemistry at the University of Illinois at Urbana-Champaign. He joined the Sloan-Kettering Institute, New York, USA, in 2006. Since 2008 he was Co-Founder, Board Member, of Adjuvance Technologies, Inc., USA.
- Webpage Memorial Sloan-Kettering Cancer Center
- Synthetic Access to the Chlorocyclopentane Cores of the Proposed Original and Revised Structures of Palau’amine,
M. S. Bultman, J. Ma, D. Y. Gin,
Angew. Chem. Int. Ed. 2008, 47, 6821–6824.
- Synthesis of QS-21-Xylose. Establishing Immuno-Potentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine,
K. Deng, M. M. Adams, P. Damani, P. O. Livingston, G. Ragupathi, D. Y. Gin,
Angew. Chem. Int. Ed. 2008, 47, 6395–6398.